Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2008 1
2010 1
2011 1
2013 1
2015 2
2017 1
2021 2
2022 1
2023 6
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025.
Rose AM, Lucaccioni H, Marsh K, Kirsebom F, Whitaker H, Emborg HD, Bolt Botnen A, O'Doherty MG, Pozo F, Hameed SS, Andrews N, Hamilton M, Trebbien R, Lauenborg Møller K, Marques DF, Murphy S, McQueenie R, Lopez-Bernal J, Cottrell S, Bucholc M, Kissling E; European IVE group; Members of the European IVE group. Rose AM, et al. Euro Surveill. 2025 Feb;30(7):2500102. doi: 10.2807/1560-7917.ES.2025.30.7.2500102. Euro Surveill. 2025. PMID: 39980423 Free PMC article.
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.
Antunes L, Rojas-Castro M, Lozano M, Martínez-Baz I, Leroux-Roels I, Borg ML, Oroszi B, Fitzgerald M, Dürrwald R, Jancoriene L, Machado A, Petrović G, Lazar M, Součková L, Bacci S, Howard J, Verdasca N, Basile L, Castilla J, Ternest S, Džiugytė A, Túri G, Duffy R, Hackmann C, Kuliese M, Gomez V, Makarić ZL, Marin A, Husa P, Nicolay N, Rose AMC; VEBIS SARI VE network team. Antunes L, et al. Influenza Other Respir Viruses. 2025 Mar;19(3):e70081. doi: 10.1111/irv.70081. Influenza Other Respir Viruses. 2025. PMID: 40059069 Free PMC article.
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Rose AMC, Pozo F, Martínez-Baz I, Mazagatos C, Bossuyt N, Cauchi JP, Petrović G, Loghin II, Vaikutyte R, Buda S, Machado A, Duffy R, Oroszi B, Howard J, Echeverria A, Andreu C, Barbezange C, Džiugytė A, Nonković D, Popescu CP, Majauskaite F, Tolksdorf K, Gomez V, Domegan L, Horváth JK, Castilla J, García M, Demuyser T, Borg ML, Tabain I, Lazar M, Kubiliute I, Dürrwald R, Guiomar R, O'Donnell J, Kristóf K, Nicolay N, Bacci S, Kissling E; VEBIS SARI VE network team; Belgium SARI Surveillance Network (BelsariNet). Rose AMC, et al. Influenza Other Respir Viruses. 2024 Feb;18(2):e13255. doi: 10.1111/irv.13255. Influenza Other Respir Viruses. 2024. PMID: 38403302 Free PMC article.
Multicentre interlaboratory analysis of routine susceptibility testing with a challenge panel of resistant strains.
Deckers C, Soleimani R, Denis O, Bogaerts P, Berhin C, Rodríguez-Villalobos H, Descy J, Hallin M, Nonhoff C, Desmet S, Magerman K, Van den Abeele AM, Lissoir B, Matheeussen V, Vernelen K, Huang TD; Belgian National Antibiogram Committee. Deckers C, et al. J Glob Antimicrob Resist. 2022 Mar;28:125-129. doi: 10.1016/j.jgar.2021.12.020. Epub 2022 Jan 10. J Glob Antimicrob Resist. 2022. PMID: 35026463 Free article.
Genomic monitoring of SARS-CoV-2 variants using sentinel SARI hospital surveillance.
Denayer S, Dufrasne FE, Monsieurs B, van Eycken R, Houben S, Seyler L, Demuyser T, van Nedervelde E, Bourgeois M, Delaere B, Magerman K, Jouck D, Lissoir B, Sion C, Reynders M, Petit E, Dauby N, Hainaut M, Laenen L, Maes P, Baele G, Dellicour S, Cuypers L, André E, Couvreur S, Brondeel R, Barbezange C, Bossuyt N, van Gucht S. Denayer S, et al. Influenza Other Respir Viruses. 2023 Oct 13;17(10):e13202. doi: 10.1111/irv.13202. eCollection 2023 Oct. Influenza Other Respir Viruses. 2023. PMID: 37840842 Free PMC article.
Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022.
De Baetselier I, Smet H, Kehoe K, Loosen I, Reynders M, Mansoor I, Filippin L, Cauchie M, Van Even E, Makki N, Schiettekatte G, Vandewal W, Glibert B, Matheeussen V, Van der Beken Y, Cartuyvels R, Steyaert S, Lemmens A, Garrino MG, Paridaens H, Lazarova E, Lissoir B, Deffontaine M, Heinrichs A, Saegeman V, Padalko E, Lecompte A, Vanden Berghe W, Kenyon C, Van den Bossche D. De Baetselier I, et al. Euro Surveill. 2024 Feb;29(7):2300318. doi: 10.2807/1560-7917.ES.2024.29.7.2300318. Euro Surveill. 2024. PMID: 38362626 Free PMC article.
Automated serum protein electrophoresis by Capillarys.
Bossuyt X, Lissoir B, Mariën G, Maisin D, Vunckx J, Blanckaert N, Wallemacq P. Bossuyt X, et al. Clin Chem Lab Med. 2003 May;41(5):704-10. doi: 10.1515/CCLM.2003.107. Clin Chem Lab Med. 2003. PMID: 12812271
Influenza versus other respiratory viruses - assessing severity among hospitalised children, Belgium, 2011 to 2020.
Fischer N, Moreels S, Dauby N, Reynders M, Petit E, Gérard M, Lacor P, Daelemans S, Lissoir B, Holemans X, Magerman K, Jouck D, Bourgeois M, Delaere B, Quoilin S, Van Gucht S, Thomas I, Bossuyt N, Barbezange C. Fischer N, et al. Euro Surveill. 2023 Jul;28(29):2300056. doi: 10.2807/1560-7917.ES.2023.28.29.2300056. Euro Surveill. 2023. PMID: 37470740 Free PMC article.
22 results